Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.

Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan W, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta SV, Wu B, Attar EC, Stone RM.

Blood. 2019 Dec 16. pii: blood.2019002140. doi: 10.1182/blood.2019002140. [Epub ahead of print]

2.

Exploring dimensions of social support and resilience when providing care at the end of life: a qualitative study.

Roper L, Donnellan W, Hanratty B, Bennett K.

Aging Ment Health. 2019 Sep;23(9):1139-1145. doi: 10.1080/13607863.2018.1484886. Epub 2018 Dec 6.

PMID:
30522340
3.

How does carer resilience change over time and care status? A qualitative longitudinal study.

Donnellan WJ, Bennett KM, Soulsby LK.

Aging Ment Health. 2019 Nov;23(11):1510-1516. doi: 10.1080/13607863.2018.1503998. Epub 2018 Nov 18.

PMID:
30449140
4.

A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis.

Couban S, Benevolo G, Donnellan W, Cultrera J, Koschmieder S, Verstovsek S, Hooper G, Hertig C, Tandon M, Dimier N, Malhi V, Passamonti F.

J Hematol Oncol. 2018 Sep 24;11(1):122. doi: 10.1186/s13045-018-0661-x.

5.

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, Swords R, Collins RH, Mannis GN, Pollyea DA, Donnellan W, Fathi AT, Pigneux A, Erba HP, Prince GT, Stein AS, Uy GL, Foran JM, Traer E, Stuart RK, Arellano ML, Slack JL, Sekeres MA, Willekens C, Choe S, Wang H, Zhang V, Yen KE, Kapsalis SM, Yang H, Dai D, Fan B, Goldwasser M, Liu H, Agresta S, Wu B, Attar EC, Tallman MS, Stone RM, Kantarjian HM.

N Engl J Med. 2018 Jun 21;378(25):2386-2398. doi: 10.1056/NEJMoa1716984. Epub 2018 Jun 2.

6.

Exploring the nature of illness perceptions in people with end-stage kidney disease.

Rees J, Chilcot J, Donnellan W, Soulsby L.

J Ren Care. 2018 Mar;44(1):19-29. doi: 10.1111/jorc.12225. Epub 2017 Oct 18.

PMID:
29047211
7.

A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia.

Donnellan W, Berdeja JG, Shipley D, Arrowsmith ER, Wright D, Lunin S, Brown R, Essell JH, Flinn IW.

Oncologist. 2017 Oct;22(10):1156-e111. doi: 10.1634/theoncologist.2017-0236. Epub 2017 Jul 7.

8.

Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.

Berdeja JG, Bauer T, Arrowsmith E, Essell J, Murphy P, Reeves JA Jr, Boccia RV, Donnellan W, Flinn I.

Br J Haematol. 2017 Apr;177(2):254-262. doi: 10.1111/bjh.14536. Epub 2017 Feb 7.

PMID:
28169430
9.

Family close but friends closer: exploring social support and resilience in older spousal dementia carers.

Donnellan WJ, Bennett KM, Soulsby LK.

Aging Ment Health. 2017 Nov;21(11):1222-1228. doi: 10.1080/13607863.2016.1209734. Epub 2016 Jul 20.

PMID:
27438380
10.

What are the factors that facilitate or hinder resilience in older spousal dementia carers? A qualitative study.

Donnellan WJ, Bennett KM, Soulsby LK.

Aging Ment Health. 2015;19(10):932-9. doi: 10.1080/13607863.2014.977771. Epub 2014 Nov 20.

PMID:
25410637
11.

Examining racial differences in diffuse large B-cell lymphoma presentation and survival.

Flowers CR, Shenoy PJ, Borate U, Bumpers K, Douglas-Holland T, King N, Brawley OW, Lipscomb J, Lechowicz MJ, Sinha R, Grover RS, Bernal-Mizrachi L, Kowalski J, Donnellan W, The A, Reddy V, Jaye DL, Foran J.

Leuk Lymphoma. 2013 Feb;54(2):268-76. doi: 10.3109/10428194.2012.708751.

12.

Treatment of Hirschsprung's disease.

Donnellan WL.

J Pediatr Surg. 1998 Jun;33(6):951-2. No abstract available.

PMID:
9660240
13.

Intraabdominal pyloromyotomy.

Donnellan WL, Cobb LM.

J Pediatr Surg. 1991 Feb;26(2):174-5. No abstract available.

PMID:
2023077
14.

Recurrent abdominal pain due to appendiceal obstruction and its relief by appendectomy.

Donnellan W.

S D J Med. 1988 Mar;41(3):25-9. No abstract available.

PMID:
3358110
15.

"H-type" urethroanal fistula.

Stephens FD, Donnellan WL.

J Pediatr Surg. 1977 Feb;12(1):95-102.

PMID:
833718
16.

Giant hemangioma with consumption coagulopathy.

Hagerman LJ, Czapek EE, Donnellan WL, Schwartz AD.

J Pediatr. 1975 Nov;87(5):766-8. No abstract available.

PMID:
1185346
17.

Low flow hypothermic renal perfusion.

Grana L, Donnellan WL, Swenson O.

Surg Gynecol Obstet. 1971 Sep;133(3):401-3. No abstract available.

PMID:
4936915
18.

Benign and malignant sacrococcygeal teratomas.

Donnellan WL, Swenson O.

CA Cancer J Clin. 1969 Nov-Dec;19(6):344-51. No abstract available.

19.

Benign and malignant sacrococcygeal teratomas.

Donnellan WA, Swenson O.

Surgery. 1968 Oct;64(4):834-46. No abstract available.

PMID:
5683810
20.

Immediate and long-term effects of acute hepatic ischemia. II. Vascular lesions in experimental liver ischemia.

Grana L, Saldana M, Donnellan WL, Swenson O.

Arch Surg. 1968 Sep;97(3):500-13. No abstract available.

PMID:
5675965

Supplemental Content

Loading ...
Support Center